Overview

Therapy De-escalation in Seminoma Stage IIA/B

Status:
Active, not recruiting

Trial end date:
2038-09-01

Target enrollment:

Participant gender:

Summary

The main objective of this trial is to test the efficacy and safety of carboplatin chemotherapy and involved node radiotherapy in patients with stage IIA/B seminoma.

Phase:

Phase 2

Details

Lead Sponsor:

Swiss Group for Clinical Cancer Research

Treatments:

Carboplatin